DNA methylation of colon mucosa in ulcerative colitis patients: Correlation with inflammatory status

Inflammatory Bowel Diseases

Volumn 17, Issue 9, 2011, Pages 1955-1965

  Saito, Shunsuke ^a   Kato, Jun ^a   Hiraoka, Sakiko ^a   Horii, Joichiro ^a   Suzuki, Hideyuki ^a   Higashi, Reiji ^a   Kaji, Eisuke ^a   Kondo, Yoshitaka ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

inflammation; methylation; ulcerative colitis

Indexed keywords

CORTICOSTEROID; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; ESTROGEN RECEPTOR ALPHA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYPERPLASTIC POLYPOSIS PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; MYOD1 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROMOTER REGION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; DNA; DNA METHYLATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; YOUNG ADULT;

EID: 80051539323     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21573     Document Type: Article

References (48)

1. Jones PA, Laird PW,. Cancer epigenetics comes of age. Nat Genet. 1999; 21: 163-167. (Pubitemid 29070360)
2. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998; 72: 141-196. (Pubitemid 27435555)
3. Kanai Y,. Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci. 2010; 101: 36-45.
4. Takami N, Osawa K, Miura Y, et al. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum. 2006; 54: 779-787.
5. Nakajima T, Enomoto S, Yamashita S, et al. Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol. 2010; 45: 37-44.
6. Baumgart DC, Sandborn WJ,. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007; 369: 1641-1657. (Pubitemid 46722637)
7. Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61: 3573-3577. (Pubitemid 32694963)
8. Tominaga K, Fujii S, Mukawa K, et al. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis. Clin Cancer Res. 2005; 11: 8880-8885. (Pubitemid 43005941)
9. Sato F, Shibata D, Harpaz N, et al. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res. 2002; 62: 6820-6822. (Pubitemid 35424066)
10. Wheeler JM, Kim HC, Efstathiou JA, et al. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut. 2001; 48: 367-371. (Pubitemid 32269565)
11. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006; 12: 989-995. (Pubitemid 43259882)
12. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high throughput assay to measure DNA methylation. Nucleic Acids Res. 2000; 28: E32.-
13. Eads CA, Lord RV, Wickramasinghe K, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 2001; 61: 3410-3418. (Pubitemid 32695034)
14. Trinh BN, Long TI, Laird PW,. DNA methylation analysis by MethyLight technology. Methods. 2001; 25: 456-462. (Pubitemid 34164018)
15. Widschwendter M, Siegmund KD, Müller HM, et al. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res. 2004; 64: 3807-3813. (Pubitemid 38697289)
16. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006; 38: 787-793 (Pubitemid 43980599)
17. Weisenberger DJ, Campan M, Long TI, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005: 33: 6823-6836. (Pubitemid 41830488)
18. Ebert MP, Mooney SH, Tonnes-Priddy L, et al. Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. Neoplasia. 2005; 7: 771-778.
19. Choi MS, Shim YH, Hwa JY, et al. Expression of DNA methyltransferases in multistep hepatocarcinogenesis. Hum Pathol. 2003; 34: 11-17. (Pubitemid 36160016)
20. Zhu YM, Huang Q, Lin J, et al. Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues. Int J Colorectal Dis. 2007; 22: 661-666. (Pubitemid 47097037)
21. Tahara T, Shibata T, Nakamura M, et al. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int J Mol Med. 2009; 23: 521-527.
22. Azarschab P, Porschen R, Gregor M, et al. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Genes Chromosomes Cancer. 2002; 35: 121-126. (Pubitemid 34919968)
23. Steinkamp M, Geerling I, Seufferlein T, et al. Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. Gastroenterology. 2003; 124: 1748-1757. (Pubitemid 36666771)
24. Konishi K, Shen L, Wang S, et al. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology. 2007; 132: 1254-1260. (Pubitemid 46627571)
25. Kawakami K, Ruszkiewicz A, Bennett G, et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer. 2006; 94: 593-598. (Pubitemid 43289765)
26. Gravina S, Vijg J,. Epigenetic factors in aging and longevity. Pflugers Arch. 2010; 459: 247-258.
27. Fraga MF,. Genetic and epigenetic regulation of aging. Curr Opin Immunol. 2009; 21: 446-453.
28. Robertson KD, Uzvolgyi E, Liang G, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 1999; 27: 2291-2298. (Pubitemid 29245646)
29. Schmidt WM, Sedivy R, Forstner B, et al. Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol Carcinog. 2007: 46: 766-772 (Pubitemid 47438727)
30. Fujii S, Katsumata D, Fujimori T,. Limits of diagnosis and molecular markers for early detection of ulcerative colitis-associated colorectal neoplasia. Digestion. 2008; 77: 2-12. (Pubitemid 351598542)
31. Moriyama T, Matsumoto T, Nakamura S, et al. Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis. Dis Colon Rectum. 2007; 50: 1384-1392. (Pubitemid 47472402)
32. Mikami T, Yoshida T, Numata Y, et al. Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumors. Am J Clin Pathol. 2007; 127: 366-373. (Pubitemid 46806329)
33. Suzuki H, Iwasaki E, Hibi T,. Helicobacter pylori and gastric cancer. Gastric Cancer. 2009; 12: 79-87.
34. Shen L, Kondo Y, Rosner GL, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 2005; 97: 1330-1338. (Pubitemid 41487800)
35. Kang GH, Lee HJ, Hwang KS, et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol. 2003; 163: 1551-1556. (Pubitemid 37175101)
36. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007; 133: 1099-1105. (Pubitemid 47494461)
37. Aust DE, Terdiman JP, Willenbucher RF, et al. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Mod Pathol. 2001; 14: 29-39. (Pubitemid 32098808)
38. Karayiannakis AJ, Syrigos KN, Efstathiou J, et al. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J Pathol. 1998; 185: 413-418. (Pubitemid 28355975)
39. Takahashi M,. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 2001; 12: 361-373. (Pubitemid 32851748)
40. Uesaka T, Nagashimada M, Yonemura S, et al. Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice. J Clin Invest. 2008; 118: 1890-1898. (Pubitemid 351632391)
41. Lin RK, Hsu HS, Chang JW, et al. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer. 2007; 55: 205-213.
42. Yamagata Y, Asada H, Tamura I, et al. DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen. Hum Reprod. 2009; 24: 1126-1132.
43. Robert MF, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet. 2003; 33: 61-65. (Pubitemid 36068683)
44. Mishra MV, Bisht KS, Sun L, et al. DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells. Mol Cancer Res. 2008; 6: 243-249. (Pubitemid 351342412)
45. Oshitani N, Kitano A, Okabe H, et al. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut. 1993; 34: 936-938. (Pubitemid 23203115)
46. Seril DN, Liao J, Yang GY, et al. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003; 24: 353-362. (Pubitemid 36432628)
47. Roessner A, Kuester D, Malfertheiner P, et al. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract. 2008; 204: 511-524.
48. Nakajima T, Maekita T, Oda I, et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2317-2321. (Pubitemid 44877064)